Tag: equity
-
DNA Storage Start-Up Gains €5M in Seed Funds
A new company developing DNA as a data storage medium with sustainable processes is raising €5 million ($US 5.22 million) in seed funding.
-
FDA Clears Digital Health Monitoring System
A developer of remote health tracking technology says the Food and Drug Administration cleared its continuous patient monitoring system for clinical use.
-
Mental Health Therapy, Tech Network Gains Early Funds
A company building a therapy and technology network for improving access to mental health providers is raising $15 million in its first venture round.
-
Residual Cancer Detection Company Launches, Raises $56M
A start-up enterprise developing personalized liquid biopsies for finding residual cancer in patients is beginning work and raising $56 million in venture funds.
-
Infographic – US, China Lead in Space Investments
Data collected by Space Capital, a venture investor in companies developing space-based technologies, shows $265 billion invested in these start-up companies since 2014.
-
Cancer Detection Start-Up Gains $4M in Seed Funds
A developer of early-stage non-invasive cancer detection tests based on research in university labs is raising $4 million in its seed venture round.
-
Gut-Brain Meds Developer Going Public in Merger
31 Oct. 2022. A developer of synthetic biology treatments for inflammatory and neurological disorders linked to the gut is becoming a public company through a special acquisition merger. Intrinsic Medicine Inc. in Seattle is joining with Phoenix Biotech Acquisition Corp. in Oakland, California, a special purpose acquisition company or SPAC, in a deal expected to…
-
Immunotherapy Start-Up Launches Collaboration, Raises $65M
A new biotechnology company is creating cancer immunotherapies that it says harness more of the full power of T-cells in the immune system to attack tumors.
-
Infographic – Q3 Digital Health Venture Funds Slide
Venture funding for start-ups worldwide applying digital technologies to health care continued to fall in the third quarter of 2022, both in deals and dollars invested.
-
“Dark Genome” Drug Discoverer Gains $37M in Early Funds
19 Oct. 2022. A biotechnology enterprise discovering new drugs from non-protein coding regions of the genome is raising €37.5 million ($US 36.6 million) in venture funds. Nucleome Therapeutics Ltd. in Oxford, U.K. is a three year-old business spun-off from genetic research labs at University of Oxford medical school. Nucleome Therapeutics is seeking new treatments for…